| REGULATORY UPDATE |
|
| Year : 2019 | Volume
: 10
| Issue : 1 | Page : 31-33 |
|
|
Indian regulatory update April–October 2018
Amita Bhave1, Lakhvinder Singh Batolar2
1 Head Regulatory Affairs, Global Drug Development India, Novartis Healthcare Private Ltd., Mumbai, Maharashtra, India
2 General Regulator Affairs Manager, Johnson and Johnson Private Limited, Mumbai, Maharashtra, India
Correspondence Address:
Amita Bhave
Novartis Healthcare Private Limited, Inspire BKC, Part of 601 and 701, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/picr.PICR_188_18
|
|
|
This document provides updates in regulatory requirements regarding conduct of clinical trials in India. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
